Company Biotie Therapies Corp OTC Markets
Equities
BIOZF
FI0009011571
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-.--% | -.--% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Antero Kallio
CEO | Chief Executive Officer | 64 | 05-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Cohen
CHM | Chairman | 68 | 16-04-30 |
Jane Wasman
BRD | Director/Board Member | 67 | 16-04-30 |
Andrew Hindman
BRD | Director/Board Member | 51 | 16-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 983,519,747 | 306,896,911 ( 31.20 %) | 2,597,952 ( 0.2641 %) | 31.20 % |
Company contact information
Biotie Therapies Oy
Uudenmaankatu 1-5
00120, Helsinki
+
![address Biotie Therapies Corp(BIOZF)](https://cdn.zonebourse.com/static/address/429104.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- BTH1V Stock
- BIOZF Stock
- Company Biotie Therapies Corp